Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effective treatments for PAH will require detailed knowledge of molecular aetiology.

International journal of clinical practice. Supplement - 1 Nov 2010

Johnson J, Loyd J, West J

Abstract excerpt

Therapies for idiopathic pulmonary arterial hypertension will need to address the underlying molecular defects, or they will be incapable of halting progression. Identification of the familial PAH gene, BMPR2, and determinants of penetrance in families with BMPR2 mutation, has provided a mechanis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Morphogenetic Protein Receptors, Type II
Share to Drug Design
Share to Estrogens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BMPR2 gene

Share to Heterozygote

Share to Hypertension, Pulmonary

Share to Mutation

Share to rac1 GTP-Binding Protein

Source

Identifiers

PMID: 20939840
DOI: 10.1111/j.1742-1241.2010.02526.x

Genes

BMPR2
PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20939840-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effective treatments for PAH will require detailed knowledge of molecular aetiology.PMID 20939840Read ↗

Molecular pathogenesis of pulmonary arterial hypertension.Semantic proximity Read ↗

Novel Advances in Modifying BMPR2 Signaling in PAHSemantic proximity Read ↗

Significance of BMPR2 mutations in pulmonary arterial hypertension.Semantic proximity Read ↗

The Genetics of Pulmonary Arterial Hypertension in the <i>Post‐BMPR2</i> EraSemantic proximity Read ↗

Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetranceSemantic proximity Read ↗

Recent advances in pulmonary arterial hypertensionSemantic proximity Read ↗

Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies.Semantic proximity Read ↗

Emerging Mechanistic Insights and Therapeutic Strategies for Pulmonary Arterial Hypertension: A Focus on Right Ventricular Dysfunction and Novel Treatment PathwaysSemantic proximity Read ↗

Pulmonary arterial hypertension: insights from genetic studies.Semantic proximity Read ↗

Interaction between Bone Morphogenetic Protein Receptor Type 2 and Estrogenic Compounds in Pulmonary Arterial HypertensionSemantic proximity Read ↗

Genetics and mediators in pulmonary arterial hypertension.Semantic proximity Read ↗

Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.